	JAK Inhibitors for Crohn's Disease: A Systematic Review and Dose-Response Network Meta-Analysis of Efficacy and Safety. JGH Open Qtaishat FA, AlKayyat A, Yasin JA, A Tamimi MA, Tarawneh J, AlDaher L, Abdallah S, Alghaniem MMA, Abunamoos A, Musa A, Ateiwi YA, Taha Y, Tamimi TA. PMID: 42022940 [PubMed]
	Gut microbiota and bile acids profiles study of ulcerative colitis and Crohn's disease patients. Front Microbiol Wang Z, Shi J, Yu Y, Zhu L, Zhu L, Tuo W, Ni J, Wu Y, Qiu S, Yu Y. PMID: 42022118 [PubMed]
	Composition of Gut Microbiota and Its Relationship with Inflammatory Markers in Healthy Individuals and Patients with Ulcerative Colitis or Crohn's Disease. J Med Invest Watanabe H, Ono Y, Oshikiri T, Tsuchiya K. PMID: 42021104 [PubMed - indexed for MEDLINE]
	Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study. Clin Res Hepatol Gastroenterol Richard N, Leroyer A, Dupont C, Turck D, Bertrand V, Wils P, Gower-Rousseau C, Guillon N, Savoye G, Ley D, Sarter H, Fumery M, EPIMAD study group. PMID: 42019917 [PubMed - as supplied by publisher]
	Thymoquinone and caffeic acid phenethyl ester mitigate experimental ulcerative colitis: a biochemical and histopathological study. Acta Cir Bras Ersak C, Ergüder E, Nojadeh JN, Altiner S, Pekcici MR. PMID: 42018894 [PubMed - indexed for MEDLINE]
	Heritability of Crohn's disease and ulcerative colitis: a Swedish nationwide population-based twin study. J Crohns Colitis Grännö O, Thunberg J, Ludvigsson JF, Kuja-Halkola R, Lindqvist CM, Halfvarson J. PMID: 42018767 [PubMed - indexed for MEDLINE]
	Utility of T2* and DWI-IVIM to distinguish inflammatory and noninflammatory strictures in Crohn's disease: a prospective cross-sectional cohort study. Eur Radiol Exp Beek KJ, van Rijn K, de Voogd F, Wassenaar NPM, Buskens C, van der Bilt J, Bemelman W, D'Haens GR, Gecse KB, Horsthuis K, Tielbeek J, Mookhoek A, Neefjes-Borst A, Gurney-Champion O, Stoker J. PMID: 42018022 [PubMed - indexed for MEDLINE]
	Optimisation before Crohn's surgery using Exclusive enteral Nutrition (OCEaN): A randomised controlled trial to determine whether preoperative exclusive enteral nutrition is more clinically and cost effective compared with standard care in patients undergoing surgery for Crohn's disease. Colorectal Dis OCEaN Collaborative Group, Badwal P, Baxter J, Brown F, Cooney R, Grimes C, Hall J, Hazel K, Kaur M, Lomer M, Pinkney T, Rowland N, Gerasimidis K, Iqbal A, Magill L, Mathers J, Oopong R. PMID: 42015557 [PubMed - indexed for MEDLINE]
	Detail Coverage and Evidence Integration: Evaluating ChatGPT 5.0 and DeepSeek R1 in Guideline-Based Crohn's Disease Applications. J Eval Clin Pract Zhou H, Yuan T, Ning Y, Mao B, Zhu M. PMID: 42013239 [PubMed - indexed for MEDLINE]
	An atypical and diagnostically challenging case of pediatric metastatic Crohn's disease. JAAD Case Rep Belkasmi I, Philip O, Jouvenet A, Catteau B, Faiz S, Ditchi Y, Vuillamy C. PMID: 42011389 [PubMed]
	Integrated RNA-seq and scRNA-seq to explore the biological mechanisms of mitophagy-related genes in ulcerative colitis. PLoS One Ma J, Xu R, Liu Y, Shao J, Xu J, Qi Y. PMID: 42008502 [PubMed - indexed for MEDLINE]
	Therapeutic Promise of the Panax Genus in Ulcerative Colitis: Unraveling the Multitarget Mechanisms of Saponins and Polysaccharides. J Agric Food Chem Li C, Zhou Y, Jiao Y, Qian X, Wang X, Chen H, Zhao L, Zhang H, Lu Q. PMID: 42008316 [PubMed - as supplied by publisher]
	Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. Acta Derm Venereol Andersen YMF, Seyed-Alinaghi F, Kristiansen MF, Thomsen SF. PMID: 42007810 [PubMed - in process]
	Effect of curcumin combined with vedolizumab on disease activity in patients with moderate to severe ulcerative colitis and its correlation with inflammatory and immune factors. Front Med (Lausanne) Zhao Y, Bao M, Niu W. PMID: 42006893 [PubMed]
	Correction: Efficacy and safety of IL-23 inhibitors in the treatment of moderate to severe ulcerative colitis: a meta-analysis based on randomized controlled trials. Front Med (Lausanne) He M, Liang H, Fan X, Sun L. PMID: 42006889 [PubMed]
	Study of serum long non-coding RNA interferon gamma antisense-1 as a biomarker of activity in Crohn's disease. Prz Gastroenterol Header DA, Ali Ibrahim AM, Ramadan AM, Dwedar FI, Aty KA. PMID: 42005950 [PubMed]
	Magnetic Resonance Enterography Predicts Long-Term Outcomes in Crohn's Disease: A Systematic Review and Meta-Analysis. JGH Open Wu S, Yang J, Jizhi S, Liu A, Chen X, Chen Z, Zheng S. PMID: 42004198 [PubMed]
	Timing of seton removal and clinical outcomes in perianal fistulizing Crohn's disease: A systematic review and meta-analysis. Colorectal Dis Horio Y, Uchino M, Tomoo Y, Nomura K, Nagano K, Kusunoki K, Kuwahara R, Kimura K, Kataoka K, Takagawa T, Ikeda M, Ikeuchi H. PMID: 42003433 [PubMed - indexed for MEDLINE]
	One-year effectiveness and safety of ustekinumab treatment in patients with ulcerative colitis: an Asan-Crohn's and Colitis Association in Daegu-Gyeongbuk (CCAiD) multicenter real-world cohort study. Intest Res Baek JE, Kim MK, Kim ES, Kim KO, Jo HH, Hwang SW, Park SH, Jang BI, Kim EY, Kim SK, Yang SK, Ye BD. PMID: 42002972 [PubMed - as supplied by publisher]
	Integrated endoscopic and medical approaches for Crohn's disease-associated strictures. Intest Res Moroi R, Kakuta Y, Masamune A. PMID: 42002971 [PubMed - as supplied by publisher]

Articles 1 - 20 / 57372

Page 1 of 2869



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy